Held the day before ENDO 09 on Tuesday, June 9, 2009 in Washington, D.C., this forum will inform Society members about the basic and clinical science of endocrine disrupting chemicals (EDCs), and will bring cutting-edge endocrinology to regulators and policymakers. Endocrine research is lacking in recent well-publicized risk assessments for EDCs such as bisphenol-A, phthalates, and perchlorate, which rely heavily on toxicological studies. Understanding the mechanisms by which EDCs alter endocrine function in child development or adult physiology is important to public health and health policy. In addition, it is critical to quantify the risk of EDC exposure to the human population. Endocrinologists are well versed in the methods required to understand the mechanism of action of chemicals that act on development and physiology. Endocrine research is critically needed to provide adequate information for effective risk assessment and development of regulations in order to inform a public health agenda.
To register please fill out the ENDO 09 registration form and fax it to the number on the form. For more information, contact Loretta Doan, PhD, Associate Director, Science Policy, at email@example.com or 301-941-0258.